Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	20.22	30.69	25.53
Graham Fair Price	-32.25	15.47	22.83
PEG	14.68	-0.43	0.38
Price/Book	-24.04	2.74	3.60
Price/Cash Flow	4669.59	1215.60	25.49
Prices/Earnings	75.97	23.99	13.63
Price/Sales	-9.12	3.60	3.96
Price/FCF	4669.59	1215.60	25.49
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-0.14	0.61	0.62
Operating Margin	-33.47	0.07	0.10
ROA	-54.63	0.01	0.02
ROE	0.07	0.03	-56.84
ROIC	0.06	0.03	-52.89
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.04	0.49	-90.89
Dividends QOQ	0.00	-1.00	-100.00
EBIT QOQ	0.17	-0.43	153.44
EPS QOQ	0.36	-0.56	53.45
FCF QOQ	5.57	-0.98	-82.33
Revenue QOQ	0.15	-0.14	-5.11
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	211.98	238.01	12.28
Days Sales Outstanding (DSO)	30.51	31.51	3.29
Inventory Turnover	0.42	0.38	-10.93
Debt/Capitalization	0.28	0.29	2.70
Quick Ratio	0.52	0.49	-6.96
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	18.73	19.31	3.12
Cash	2.50	1.38	-44.91
Capex	-1.49	-0.70	53.45
Free Cash Flow	2.65	0.04	-98.36
Revenue	17.05	14.69	-13.81
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.64	1.84	12.17
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	4.53	7.01	54.50
Naive Interpretation	Member

06 - Financial Health · Weak

Rating